The STXBP1 Foundation and Children’s Hospital of Philadelphia Announce Phase 2 of the STARR Study for Clinical Trial Readiness, and Clinic Expansion
STXBP1 Census - Q2 2024
Over 3,000 People Have Signed our Petition to the CDC for an ICD-10 Code
Cain Labs and Duncan Neurological Research Institute researchers find a novel first-in-class gene therapy alleviates symptoms in animal models of STXBP1 disorder
Strides in STXBP1: What Happened Last Month in STXBP1 Research?
People Magazine Feature Article on Flo
Encoded Therapeutics highlights progress of preclinical programs for including STXBP1-related disorders (STXBP1-RD)
Capsida Biotherapeutics to Present New Data on its Wholly Owned Gene Therapy Programs in Genetic Epilepsy
Strides in STXBP1: What Happened Last Month in STXBP1 Research?